Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
Peter Schmid, Roberto Salgado, Y.H. Park, Eva Muñoz‐Couselo, S.-B. Kim, Joohyuk Sohn and 10 more
- Rank
- 27 of 3,211
- Percentile
- top 0.9%
- Where
- Annals of Oncology, 2020
- Citations
- 412
From the 2020 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.